{
  "paper_metadata": {
    "pmid": "37946256",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on TTR variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 4428,
        "demographics": "Predominantly male, mean age at symptom onset 56.6 years.",
        "phenotype": "Symptomatic patients with various phenotypes including predominantly cardiac and neurologic."
      },
      "penetrance_data": {
        "total_carriers_observed": 1707,
        "affected_count": 4428,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 62,
          "age_at_onset": 56,
          "age_at_diagnosis": 60,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Predominantly cardiac phenotype.",
          "evidence_sentence": "The majority of symptomatic patients were male (70.8%) with a mean (standard deviation [SD]) age at symptom onset of 56.6 (17.9) years."
        }
      ],
      "functional_data": {
        "summary": "The V30M variant is known to destabilize the TTR protein, leading to amyloid fibril formation.",
        "assays": [
          "Neuropathy Impairment Score in the Lower Limbs (NIS-LL)",
          "Karnofsky Performance Status Scale Score"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "V30M remains the most prevalent genotype in Europe (62.2%), South America (78.6%), and Japan (74.2%).",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V30M variant is the most studied and prevalent in ATTR amyloidosis.",
      "key_quotes": [
        "V30M remained the most prevalent genotype in Europe (62.2%), South America (78.6%), and Japan (74.2%).",
        "Asymptomatic gene carriers were 58.5% female with a mean age at enrollment of 41.9 years (SD 15.5)."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Demographics of symptomatic patients according to genotype category",
      "variants_extracted": 1
    },
    {
      "table_name": "Table 2",
      "table_caption": "Demographics of asymptomatic gene carriers according to genotype category",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text and tables."
  }
}